Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feedercanada.ca
Health Canada RSS - Drug Products, Drugs and Health Products
Get the latest updates from Health Canada RSS - Drug Products, Drugs and Health Products directly as they happen.
Follow now 262 followers
Latest posts
Last updated 10 days ago
Revised post notice of compliance changes quality guidances: ICH Q12 interim implementation for biologics and Schedule C drugs
10 days ago
Health Canada is implementing ICH Q12 in a phased manner, with an...
Consultation on the proposed phased implementation of the incorporated by reference list for the Ministerial Reliance Order
20 days ago
Health Canada is seeking feedback from May 5, 2026, to June 4...
Final notice: Classification of topical products containing human-derived exosomes, human extracellular vesicles, or human cell-conditioned media
about 2 months ago
Final notice to communicate Health Canada's position on the classification of topical...
Consultation: Canadian Access, Watch, Reserve classification of antimicrobial drugs for human use
about 2 months ago
Health Canada is seeking feedback from April 9, 2026, to June 8...
Summary Basis of Decision for Tyruko
3 months ago
Health Canada Summary Basis of Decision 2026/02/11. Tyruko, natalizumab, 300 mg/15 mL...
Summary Basis of Decision for Yesintek & Yesintek I.V.
3 months ago
Health Canada Summary Basis of Decision January 19, 2026. Yesintek and Yesintek...
Summary Basis of Decision for Ahzantive
3 months ago
Health Canada Summary Basis of Decision 2026-02-02. Ahzantive, 2 mg/0.05 mL aflibercept...
Summary Basis of Decision for Enzeevu
3 months ago
Health Canada Summary Basis of Decision 2026-01-19. Enzeevu, aflibercept, 2 mg/0.05 mL...
Summary Basis of Decision for Tevimbra
3 months ago
Health Canada Summary Basis of Decision 2026-02-11. Tevimbra, tislelizumab 100 mg/10 mL...
Summary Basis of Decision for Nilemdo
3 months ago
Health Canada Summary Basis of Decision 2026-02-02. Nilemdo, 180 mg bempedoic acid...
Summary Basis of Decision for Zurzuvae
3 months ago
Health Canada Summary Basis of Decision 2026-02-19. Zurzuvae, zuranolone, 20 mg, 25...
Summary Basis of Decision for Elfabrio
3 months ago
Health Canada Summary Basis of Decision 2026-02-09. Elfabrio, pegunigalsidase alfa 5 mg/2.5...